Nifty

:

23431.50

Sensex

:

74764.23

-203.60 (-0.86%)
-813.35 (-1.08%)

Login

Nifty
Sensex

:
:

23431.50
74764.23

-203.60 (-0.86%)
-813.35 (-1.08%)

Venus Remedies Ltd.

Pharmaceuticals & Drugs

Rating :

75/99

BSE: 526953 | NSE: VENUSREM

Watchlist

NSE BSE

1650.20

09-Sep-2026

Open
High
Low
Previous Close

1620
1700
1620
1625.20

Volume
Traded Value (lacs)
52 Week High
52 Week Low

25233
42103498
2044.3
424

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,211.03
19.03
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

2,181.43
0.60%
3.22

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

6.76
5.10
8.56

EBITDA CAGR (%)

10 Years
5 Years
3 Years

11.25
18.85
19.83

PAT CAGR (%)

10 Years
5 Years
3 Years

-
20.35
53.37

P:E (Median)

8 Years
5 Years
3 Years

11.67
13.82
15.79

P:BV (Average)

8 Years
5 Years
3 Years

0.86
1.13
1.34

EV:EBITDA (Average)

8 Years
5 Years
3 Years

7.22
6.47
7.12

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 178.80 137.13 30.39% 259.01 196.74 31.65% 179.95 172.20 4.50% 192.65 169.67 13.54%
Expenses 142.24 119.20 19.33% 199.58 171.49 16.38% 143.23 149.63 -4.28% 162.81 156.75 3.87%
EBITDA 36.56 17.93 103.90% 59.43 25.25 135.37% 36.72 22.57 62.69% 29.84 12.92 130.96%
EBIDTM 20.45% 13.08% 22.95% 12.83% 20.41% 13.11% 15.49% 7.61%
Other Income 2.55 2.72 -6.25% 4.63 4.07 13.76% 2.41 2.08 15.87% 1.68 8.06 -79.16%
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 6.51 5.95 9.41% 6.50 4.49 44.77% 6.32 5.20 21.54% 5.92 6.17 -4.05%
PBT 32.60 14.70 121.77% 57.56 24.83 131.82% 32.81 29.36 11.75% 25.60 14.81 72.86%
Tax 7.07 3.01 134.88% 14.11 10.04 40.54% 7.89 5.28 49.43% 6.36 5.55 14.59%
PAT 25.53 11.69 118.39% 43.45 14.79 193.78% 24.92 24.08 3.49% 19.24 9.26 107.78%
PATM 14.28% 8.52% 16.78% 7.52% 13.85% 13.98% 9.99% 5.46%
EPS 19.05 8.72 118.46% 32.43 11.04 193.75% 18.60 17.97 3.51% 14.36 6.91 107.81%

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 178.86 137.18 30.38% 259.40 197.66 31.24% 180.26 176.52 2.12% 192.75 170.10 13.32%
Expenses 144.67 121.80 18.78% 195.97 165.97 18.08% 142.74 158.50 -9.94% 161.79 162.54 -0.46%
EBITDA 34.19 15.38 122.30% 63.43 31.69 100.16% 37.52 18.02 108.21% 30.96 7.56 309.52%
EBIDTM 19.12% 11.21% 24.45% 16.03% 20.81% 10.21% 16.06% 4.44%
Other Income 2.62 3.41 -23.17% 4.95 4.07 21.62% 2.52 2.37 6.33% 1.71 7.93 -78.44%
Interest 0.00 0.01 -100.00% 0.01 0.01 0.00% 0.01 0.01 0.00% 0.01 0.02 -50.00%
Depreciation 6.77 6.18 9.55% 6.76 4.71 43.52% 6.56 5.41 21.26% 6.17 6.40 -3.59%
PBT 30.04 12.60 138.41% 61.61 31.04 98.49% 33.47 24.88 34.53% 26.49 9.07 192.06%
Tax 7.07 3.00 135.67% 14.12 10.04 40.64% 7.89 5.28 49.43% 6.36 5.56 14.39%
PAT 22.97 9.60 139.27% 47.49 21.00 126.14% 25.58 19.60 30.51% 20.13 3.51 473.50%
PATM 12.84% 7.00% 18.31% 10.62% 14.19% 11.10% 10.44% 2.06%
EPS 17.18 7.18 139.28% 35.52 15.71 126.10% 19.13 14.66 30.49% 15.06 2.63 472.62%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 810.41 768.73 644.47 575.21 537.66 576.71 514.62 320.23 301.84 355.07 375.45 Net Sales Growth 19.93% 19.28% 12.04% 6.98% -6.77% 12.07% 60.70% 6.09% -14.99% -5.43% Cost Of Goods Sold 397.39 387.25 374.79 352.22 336.70 377.50 336.68 176.81 181.78 205.42 186.69 Gross Profit 413.02 381.49 269.68 223.00 200.96 199.22 177.94 143.42 120.06 149.65 188.76 GP Margin 50.96% 49.63% 41.85% 38.77% 37.38% 34.54% 34.58% 44.79% 39.78% 42.15% 50.28% Total Expenditure 647.86 624.82 569.47 514.32 476.14 507.89 467.76 277.16 267.55 311.51 328.16 Power & Fuel Cost - 6.43 4.91 4.99 4.17 3.78 3.39 3.41 3.50 3.02 3.08 % Of Sales - 0.84% 0.76% 0.87% 0.78% 0.66% 0.66% 1.06% 1.16% 0.85% 0.82% Employee Cost - 79.66 67.21 57.57 47.67 43.75 35.89 33.79 30.26 27.82 25.02 % Of Sales - 10.36% 10.43% 10.01% 8.87% 7.59% 6.97% 10.55% 10.03% 7.84% 6.66% Manufacturing Exp. - 35.36 31.19 22.40 25.46 25.48 20.63 18.35 18.98 34.28 75.01 % Of Sales - 4.60% 4.84% 3.89% 4.74% 4.42% 4.01% 5.73% 6.29% 9.65% 19.98% General & Admin Exp. - 25.80 23.15 21.23 18.63 15.01 13.76 15.22 9.79 11.86 12.20 % Of Sales - 3.36% 3.59% 3.69% 3.47% 2.60% 2.67% 4.75% 3.24% 3.34% 3.25% Selling & Distn. Exp. - 89.04 67.58 55.62 43.24 42.37 57.40 29.59 23.24 29.11 26.17 % Of Sales - 11.58% 10.49% 9.67% 8.04% 7.35% 11.15% 9.24% 7.70% 8.20% 6.97% Miscellaneous Exp. - 1.28 0.64 0.31 0.26 0.00 0.00 0.00 0.00 0.00 26.17 % Of Sales - 0.17% 0.10% 0.05% 0.05% 0% 0% 0% 0% 0% 0% EBITDA 162.55 143.91 75.00 60.89 61.52 68.82 46.86 43.07 34.29 43.56 47.29 EBITDA Margin 20.06% 18.72% 11.64% 10.59% 11.44% 11.93% 9.11% 13.45% 11.36% 12.27% 12.60% Other Income 11.27 11.45 15.77 11.32 10.17 8.43 17.76 3.58 4.51 1.19 3.10 Interest 0.00 0.00 0.00 0.00 0.00 0.00 12.73 13.05 25.15 35.44 35.87 Depreciation 25.25 24.69 21.62 25.55 31.37 32.58 34.28 31.05 32.95 32.73 39.32 PBT 148.57 130.67 69.16 46.65 40.33 44.67 17.62 2.55 -19.30 -23.42 -24.80 Tax 35.43 31.36 26.51 16.15 11.36 -4.32 -13.21 1.96 -1.15 3.16 -4.56 Tax Rate 23.85% 24.00% 33.53% 34.62% 28.17% -9.67% -32.17% -31.31% 4.07% -13.49% 18.39% PAT 113.14 99.31 52.56 30.50 28.96 48.99 54.27 -8.23 -27.11 -26.58 -20.24 PAT before Minority Interest 113.14 99.31 52.56 30.50 28.96 48.99 54.27 -8.23 -27.11 -26.58 -20.24 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 13.96% 12.92% 8.16% 5.30% 5.39% 8.49% 10.55% -2.57% -8.98% -7.49% -5.39% PAT Growth 89.13% 88.95% 72.33% 5.32% -40.89% -9.73% - - - - EPS 84.43 74.11 39.22 22.76 21.61 36.56 40.50 -6.14 -20.23 -19.84 -15.10

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 811.27 769.60 652.89 601.45 555.51 600.18 548.12 339.33 321.89 372.41 400.04 Net Sales Growth 19.05% 17.88% 8.55% 8.27% -7.44% 9.50% 61.53% 5.42% -13.57% -6.91% Cost Of Goods Sold 397.39 387.27 378.62 354.69 330.99 386.98 340.79 174.31 181.95 205.08 227.07 Gross Profit 413.88 382.32 274.27 246.76 224.51 213.20 207.33 165.02 139.94 167.33 172.97 GP Margin 51.02% 49.68% 42.01% 41.03% 40.42% 35.52% 37.83% 48.63% 43.47% 44.93% 43.24% Total Expenditure 645.17 622.32 584.36 541.85 495.49 538.07 494.35 298.52 289.37 332.94 349.32 Power & Fuel Cost - 6.87 6.36 6.35 5.52 4.71 4.58 4.73 4.86 4.29 4.14 % Of Sales - 0.89% 0.97% 1.06% 0.99% 0.78% 0.84% 1.39% 1.51% 1.15% 1.03% Employee Cost - 83.48 75.46 66.95 57.05 52.33 46.02 46.02 42.10 39.31 34.27 % Of Sales - 10.85% 11.56% 11.13% 10.27% 8.72% 8.40% 13.56% 13.08% 10.56% 8.57% Manufacturing Exp. - 41.57 36.22 28.77 32.40 31.57 22.86 20.84 21.01 36.10 42.48 % Of Sales - 5.40% 5.55% 4.78% 5.83% 5.26% 4.17% 6.14% 6.53% 9.69% 10.62% General & Admin Exp. - 27.16 26.24 23.70 20.70 16.67 16.45 17.57 11.85 13.52 13.26 % Of Sales - 3.53% 4.02% 3.94% 3.73% 2.78% 3.00% 5.18% 3.68% 3.63% 3.31% Selling & Distn. Exp. - 74.68 60.81 61.09 48.58 45.80 63.64 35.05 27.60 34.65 28.10 % Of Sales - 9.70% 9.31% 10.16% 8.75% 7.63% 11.61% 10.33% 8.57% 9.30% 7.02% Miscellaneous Exp. - 1.28 0.64 0.31 0.26 0.00 0.00 0.00 0.00 0.00 28.10 % Of Sales - 0.17% 0.10% 0.05% 0.05% 0% 0% 0% 0% 0% 0% EBITDA 166.10 147.28 68.53 59.60 60.02 62.11 53.77 40.81 32.52 39.47 50.72 EBITDA Margin 20.47% 19.14% 10.50% 9.91% 10.80% 10.35% 9.81% 12.03% 10.10% 10.60% 12.68% Other Income 11.80 12.58 15.95 11.58 10.32 8.31 19.63 5.31 6.09 2.39 4.28 Interest 0.03 0.04 0.07 0.09 0.12 0.48 13.02 13.34 25.41 35.56 36.38 Depreciation 26.26 25.67 22.51 26.44 32.30 33.53 35.28 32.01 33.98 33.83 40.26 PBT 151.61 134.15 61.91 44.64 37.93 36.41 25.11 0.78 -20.77 -27.53 -21.64 Tax 35.44 31.36 26.51 16.15 11.36 -4.32 -13.21 1.96 -1.15 3.16 -4.56 Tax Rate 23.38% 23.38% 36.91% 36.18% 29.95% -11.86% -27.21% -24.41% 3.87% -11.48% 21.07% PAT 116.17 102.79 45.31 28.49 26.57 40.72 61.77 -10.00 -28.57 -30.69 -17.08 PAT before Minority Interest 116.17 102.79 45.31 28.49 26.57 40.72 61.77 -10.00 -28.57 -30.69 -17.08 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 14.32% 13.36% 6.94% 4.74% 4.78% 6.78% 11.27% -2.95% -8.88% -8.24% -4.27% PAT Growth 116.29% 126.86% 59.04% 7.23% -34.75% -34.08% - - - - EPS 86.69 76.71 33.81 21.26 19.83 30.39 46.10 -7.46 -21.32 -22.90 -12.75

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 689.63 589.49 508.59 478.05 449.41 400.18 332.25 340.95 367.99 394.23 Share Capital 13.37 13.37 13.37 13.37 13.37 12.34 12.34 12.34 12.34 12.34 Total Reserves 676.26 576.13 495.22 464.68 436.05 374.09 319.91 328.61 355.65 381.89 Non-Current Liabilities 28.20 18.48 59.86 58.17 45.95 58.81 96.03 136.75 157.89 179.52 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 23.92 60.88 86.02 112.69 Unsecured Loans 0.00 0.00 38.68 38.68 38.68 47.52 48.34 55.20 50.84 49.13 Long Term Provisions 2.81 2.90 10.26 8.85 7.95 7.38 6.63 5.32 4.50 4.29 Current Liabilities 158.23 105.23 72.81 72.67 82.61 87.82 215.98 254.46 222.61 193.71 Trade Payables 110.77 68.60 51.74 48.51 49.63 68.36 33.96 33.41 27.19 30.56 Other Current Liabilities 43.15 30.55 20.02 23.27 32.23 18.78 99.99 107.61 76.87 45.70 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 81.42 108.92 117.23 115.70 Short Term Provisions 4.32 6.08 1.05 0.89 0.75 0.68 0.61 4.52 1.32 1.76 Total Liabilities 876.06 713.20 641.26 608.89 577.97 546.81 644.26 732.16 748.49 767.46 Net Block 214.62 214.14 202.76 199.68 224.67 244.20 271.47 346.89 369.93 389.38 Gross Block 606.74 600.87 581.97 568.50 578.19 581.73 589.77 674.06 669.01 655.78 Accumulated Depreciation 392.12 386.73 379.21 368.82 353.52 337.53 318.30 327.17 299.08 266.40 Non Current Assets 470.26 332.26 280.26 290.70 313.57 333.08 360.33 478.57 499.96 517.54 Capital Work in Progress 51.36 26.39 21.08 26.10 25.23 25.11 24.63 64.76 64.76 66.25 Non Current Investment 163.95 54.96 0.16 0.14 0.14 0.14 0.14 0.14 0.14 28.74 Long Term Loans & Adv. 35.41 33.56 51.76 62.55 61.96 62.34 64.08 66.78 65.13 33.17 Other Non Current Assets 4.91 3.21 4.50 2.23 1.57 1.29 0.00 0.00 0.00 0.00 Current Assets 405.80 380.95 361.00 318.19 264.41 213.74 283.94 253.59 248.53 249.93 Current Investments 73.80 29.28 19.09 20.13 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 129.37 100.49 117.81 113.60 125.63 119.69 136.44 140.94 135.98 139.69 Sundry Debtors 116.39 99.26 89.54 84.92 30.41 16.44 29.78 31.39 44.15 41.91 Cash & Bank 28.03 77.99 67.64 53.30 49.97 30.24 1.44 1.28 3.64 3.15 Other Current Assets 58.21 9.34 8.27 1.78 58.40 47.36 116.28 79.98 64.77 65.18 Short Term Loans & Adv. 53.93 64.59 58.65 44.46 53.15 41.66 60.56 74.83 59.93 65.18 Net Current Assets 247.57 275.71 288.18 245.53 181.80 125.92 67.96 -0.87 25.93 56.22 Total Assets 876.06 713.21 641.26 608.89 577.98 546.82 644.27 732.16 748.49 767.47

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 663.75 560.95 487.55 460.34 440.45 400.28 323.37 332.52 361.91 388.67 Share Capital 13.37 13.37 13.37 13.37 13.37 12.34 12.34 12.34 12.34 12.34 Total Reserves 650.38 547.58 474.18 446.97 427.08 374.19 311.03 320.18 349.57 376.33 Non-Current Liabilities 28.20 18.48 59.86 58.17 45.95 58.12 95.82 136.68 158.47 179.52 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.09 24.19 61.29 86.60 112.69 Unsecured Loans 0.00 0.00 38.68 38.68 38.68 46.74 47.87 54.73 50.84 49.13 Long Term Provisions 2.81 2.90 10.26 8.85 7.95 7.38 6.63 5.32 4.50 4.29 Current Liabilities 161.76 136.29 79.42 82.57 92.74 97.45 224.58 263.62 230.38 196.81 Trade Payables 113.49 91.86 53.18 50.84 50.17 71.36 36.70 36.00 29.33 29.73 Other Current Liabilities 43.95 36.65 22.53 27.23 37.76 21.10 101.70 110.30 78.47 46.16 Short Term Borrowings 0.00 1.69 2.65 3.61 4.06 4.30 85.58 112.80 121.26 119.16 Short Term Provisions 4.32 6.08 1.05 0.89 0.75 0.68 0.61 4.52 1.32 1.76 Total Liabilities 853.71 715.72 626.83 601.08 579.14 555.85 643.77 732.82 750.76 765.00 Net Block 231.60 229.42 218.53 215.96 240.94 261.68 289.37 364.45 389.20 406.18 Gross Block 645.35 636.80 617.51 603.75 612.50 616.32 623.96 707.02 702.77 686.50 Accumulated Depreciation 413.75 407.38 398.98 387.78 371.57 354.63 334.59 342.57 313.57 280.32 Non Current Assets 458.50 318.81 267.30 278.25 301.10 321.82 349.77 467.39 490.50 505.60 Capital Work in Progress 51.36 26.39 21.08 26.10 25.23 25.11 24.63 64.76 64.76 66.25 Non Current Investment 163.82 54.82 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 6.82 4.97 23.16 33.95 33.36 35.03 35.77 38.18 36.53 33.17 Other Non Current Assets 4.91 3.21 4.50 2.23 1.57 0.00 0.00 0.00 0.00 0.00 Current Assets 395.20 396.92 359.52 322.83 278.04 234.03 294.00 265.43 260.27 259.41 Current Investments 73.80 29.28 19.09 20.13 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 129.37 100.49 121.69 119.94 125.64 119.99 141.12 142.73 138.17 140.60 Sundry Debtors 103.28 112.22 80.50 76.66 38.60 32.04 30.69 38.04 47.27 47.29 Cash & Bank 29.61 80.10 68.09 54.45 50.40 31.42 2.13 2.81 3.98 3.56 Other Current Assets 59.15 9.34 8.27 1.78 63.40 50.58 120.06 81.85 70.84 67.96 Short Term Loans & Adv. 54.87 65.48 61.88 49.87 58.39 44.88 64.34 76.70 66.00 67.96 Net Current Assets 233.45 260.63 280.11 240.26 185.30 136.59 69.43 1.81 29.88 62.59 Total Assets 853.70 715.73 626.82 601.08 579.14 555.85 643.77 732.82 750.77 765.01

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 151.09 83.10 35.38 28.05 41.00 132.34 77.75 43.65 51.58 61.77 PBT 130.67 69.16 46.65 40.33 44.67 17.62 2.55 -19.30 -23.42 -24.80 Adjustment 17.35 16.12 19.36 22.25 24.83 21.59 40.39 59.20 64.73 69.30 Changes in Working Capital 37.33 12.74 -15.15 -34.53 -28.50 69.69 20.37 3.75 10.27 17.27 Cash after chg. in Working capital 185.36 98.02 50.87 28.05 41.00 108.89 63.31 43.65 51.58 61.77 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -34.27 -14.92 -15.48 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 23.44 14.44 0.00 0.00 0.00 Cash From Investing Activity -181.57 -76.20 -6.94 -50.81 -16.75 55.98 -4.64 -11.27 -11.48 -18.06 Net Fixed Assets -30.84 -24.21 -8.45 8.82 3.42 7.56 124.42 -5.05 -11.74 18.95 Net Investments -153.51 -64.99 1.02 -20.13 0.00 0.00 0.00 0.00 28.60 0.00 Others 2.78 13.00 0.49 -39.50 -20.17 48.42 -129.06 -6.22 -28.34 -37.01 Cash from Financing Activity -1.39 0.00 0.00 0.00 -9.13 -161.88 -72.35 -34.74 -39.61 -43.60 Net Cash Inflow / Outflow -31.86 6.90 28.44 -22.76 15.12 26.45 0.76 -2.36 0.49 0.11 Opening Cash & Equivalents 55.41 48.51 20.07 42.83 27.70 0.00 0.50 3.64 3.15 3.04 Closing Cash & Equivalent 23.54 55.41 48.51 20.07 42.83 26.45 1.26 1.28 3.64 3.15

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 155.77 86.44 37.29 36.63 41.10 131.84 77.60 45.33 31.19 58.93 PBT 134.15 61.87 44.64 37.93 36.41 25.11 0.78 -20.77 -27.53 -21.64 Adjustment 18.37 17.08 20.23 23.33 26.33 21.89 41.56 60.72 66.24 70.61 Changes in Working Capital 37.52 22.42 -12.11 -24.63 -21.64 61.39 20.82 5.37 -7.52 9.96 Cash after chg. in Working capital 190.04 101.36 52.77 36.63 41.10 108.39 63.16 45.33 31.19 58.93 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -34.27 -14.92 -15.48 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 23.44 14.44 0.00 0.00 0.00 Cash From Investing Activity -181.57 -76.25 -7.21 -50.83 -16.73 56.49 -4.75 -11.33 -11.48 -18.32 Net Fixed Assets -30.84 -24.21 -8.45 8.82 3.42 7.56 124.42 -5.05 -11.74 18.95 Net Investments -153.51 -64.99 1.02 -20.13 0.00 0.00 0.00 0.00 28.60 0.00 Others 2.78 12.95 0.22 -39.52 -20.15 48.93 -129.17 -6.28 -28.34 -37.27 Cash from Financing Activity -3.12 -1.02 -1.08 -0.57 -9.48 -162.24 -73.00 -35.17 -39.23 -44.13 Net Cash Inflow / Outflow -28.91 9.18 28.99 -14.77 14.90 26.09 -0.15 -1.17 -19.52 -3.51 Opening Cash & Equivalents 57.52 48.96 21.21 43.26 28.88 1.94 2.03 3.98 0.00 7.07 Closing Cash & Equivalent 25.12 57.52 48.96 21.21 43.26 28.88 1.94 2.81 -19.52 3.56

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 515.92 441.01 380.48 357.63 336.21 313.10 269.21 276.25 298.16 319.42 ROA 12.50% 7.76% 4.88% 4.88% 8.71% 9.11% -1.20% -3.66% -3.51% -2.53% ROE 15.53% 9.57% 6.18% 6.25% 11.72% 15.10% -2.44% -7.65% -6.98% -4.83% ROCE 20.43% 13.91% 8.77% 8.03% 9.55% 10.80% 1.15% -0.48% 1.75% 1.50% Fixed Asset Turnover 1.27 1.09 1.00 0.94 0.99 0.88 0.51 0.45 0.54 0.57 Receivable days 51.20 53.46 55.35 39.15 14.83 16.39 34.86 45.68 44.23 46.56 Inventory Days 54.57 61.82 73.42 81.20 77.63 90.83 158.08 167.43 141.69 134.83 Payable days 84.53 58.60 51.95 53.20 57.04 55.46 42.49 37.63 31.43 27.90 Cash Conversion Cycle 21.23 56.68 76.82 67.15 35.41 51.76 150.45 175.48 154.49 153.50 Total Debt/Equity 0.00 0.00 0.08 0.08 0.09 0.12 0.65 0.86 0.82 0.78 Interest Cover 0.00 0.00 0.00 0.00 0.00 4.23 0.52 -0.12 0.34 0.31

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 496.56 419.65 364.74 344.38 329.50 313.18 262.01 269.42 293.23 314.92 ROA 13.10% 6.75% 4.64% 4.50% 7.18% 10.30% -1.45% -3.85% -4.05% -2.12% ROE 16.79% 8.64% 6.01% 5.90% 9.85% 17.40% -3.05% -8.23% -8.18% -4.13% ROCE 21.88% 13.17% 8.67% 7.72% 7.89% 12.37% 0.90% -0.67% 1.17% 2.00% Fixed Asset Turnover 1.20 1.04 0.99 0.91 0.98 0.88 0.51 0.46 0.54 0.59 Receivable days 51.10 53.87 47.69 37.87 21.48 20.89 36.97 48.37 46.34 49.67 Inventory Days 54.51 62.11 73.32 80.68 74.69 86.94 152.66 159.26 136.61 129.51 Payable days 96.77 69.91 53.52 55.69 57.31 57.86 42.82 37.91 30.30 26.74 Cash Conversion Cycle 8.84 46.06 67.48 62.86 38.86 49.96 146.80 169.72 152.65 152.44 Total Debt/Equity 0.00 0.00 0.08 0.09 0.10 0.13 0.68 0.90 0.85 0.80 Interest Cover 3656.40 1099.26 477.45 322.44 76.69 4.73 0.40 -0.17 0.23 0.41

Top Investors:

tikri partners llp

rajni tarun jain

acadian emerging markets micro-cap equity master fund

nisarg ajaykumar vakharia

investor education & protection fund (iepf(

Annual Reports:

News Update:

Venus Remedies - Quarterly Results
21st Jul 2026, 00:00 AM

Read More
Venus Remedies secures renewal of DSIR R&D recognition for VMRC
4th Jun 2026, 17:45 PM

The renewal confirms that VMRC continues to meet these conditions
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback